Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.66% | -504.89% | 70.20% | 52.69% | 57.35% |
| Total Depreciation and Amortization | 0.00% | 68.97% | 44.83% | 25.93% | 84.62% |
| Total Amortization of Deferred Charges | 73.92% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 169.38% | 138.97% | -115.99% | -83.36% | -102.44% |
| Change in Net Operating Assets | 84.91% | -74.78% | 3.33% | -263.77% | -1,465.51% |
| Cash from Operations | 60.63% | -355.41% | -21.67% | -94.15% | -368.47% |
| Capital Expenditure | 2,642.86% | -1,766.13% | -2,154.55% | -84.75% | 48.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2,642.86% | -891.94% | -7,081.82% | -84.75% | 48.78% |
| Total Debt Issued | -- | 150.00% | -16.67% | 25.00% | -100.00% |
| Total Debt Repaid | -62.70% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 437.96% | -61.23% | -16.67% | 67.08% | -172.70% |
| Foreign Exchange rate Adjustments | 0.00% | 0.00% | 0.00% | -200.00% | 66.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.39% | -84.03% | -205.83% | -21.91% | -2,862.91% |